Johnson & Johnson logo

JNJ - Johnson & Johnson Share Price

$158.46 -4.3  -2.6%

Last Trade - 26/02/21

Large Cap
Market Cap £298.98bn
Enterprise Value £306.22bn
Revenue £59.28bn
Position in Universe 17th / 6715
Unlock JNJ Revenue
Relative Strength (%)
1m -6.65%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -8.75%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 03rd Jan 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
71,890 76,450 81,581 82,059 82,584 82,584 88,863 93,398 +2.8%
+25.8 -2.5 +11.1 +13.7 -9.0 +2.2 +23.1 +8.87
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 03 January 2021, Johnson &Johnson revenues increased 1% to $82.58B. Net income beforeextraordinary items decreased 5% to $14.41B. Revenuesreflect Pharmaceutical segment increase of 8% to $45.57B,Consumer segment increase of 1% to $14.05B, United Statessegment increase of 2% to $43.13B. Net income was offset byResearch and development expense increase of 7% to $12.16B(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for JNJ
Graphical History


JNJ Revenue Unlock JNJ Revenue

Net Income

JNJ Net Income Unlock JNJ Revenue

Normalised EPS

JNJ Normalised EPS Unlock JNJ Revenue

PE Ratio Range

JNJ PE Ratio Range Unlock JNJ Revenue

Dividend Yield Range

JNJ Dividend Yield Range Unlock JNJ Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
JNJ EPS Forecasts Unlock JNJ Revenue
Profile Summary

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Last Annual January 3rd, 2021
Last Interim January 3rd, 2021
Incorporated November 10, 1887
Public Since September 25, 1944
No. of Shareholders: 132,376
No. of Employees: 134,500
Sector Healthcare
Industry Pharmaceuticals
Index Dow Jones Composite , Dow Jones Industrial Average , FTSE Global 100, S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 2,628,679,824
Free Float (0.0%)
Eligible for
JNJ Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for JNJ
Upcoming Events for JNJ
Monday 12th April, 2021 Estimate
Q1 2021 Johnson & Johnson Earnings Release
Tuesday 20th April, 2021
Q1 2021 Johnson & Johnson Earnings Call
Frequently Asked Questions for Johnson & Johnson
What is the Johnson & Johnson share price?

As of 26/02/21, shares in Johnson & Johnson are trading at $158.46, giving the company a market capitalisation of £298.98bn. This share price information is delayed by 15 minutes.

How has the Johnson & Johnson share price performed this year?

Shares in Johnson & Johnson are currently trading at $158.46 and the price has moved by 13.9% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Johnson & Johnson price has moved by -12.13% over the past year.

What are the analyst and broker recommendations for Johnson & Johnson?

Of the analysts with advisory recommendations for Johnson & Johnson, there are there are currently 6 "buy" , 5 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Johnson & Johnson is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Johnson & Johnson next release its financial results?

Johnson & Johnson is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-01-03
What is the Johnson & Johnson dividend yield?

The Johnson & Johnson dividend yield is 2.51% based on the trailing twelve month period.

Does Johnson & Johnson pay a dividend?

Last year, Johnson & Johnson paid a total dividend of 3.98, and it currently has a trailing dividend yield of 2.51%. Looking ahead, Johnson & Johnson has not announced an ex-dividend date yet and the next dividend pay date is 2021-03-09.

When does Johnson & Johnson next pay dividends?

Johnson & Johnson has yet to annouce their ex-dividend date and the next dividend pay date is 2021-03-09. The historic dividend yield on Johnson & Johnson shares is currently 2.51%.

How do I buy Johnson & Johnson shares?

To buy shares in Johnson & Johnson you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Johnson & Johnson?

Shares in Johnson & Johnson are currently trading at $158.46, giving the company a market capitalisation of £298.98bn.

Where are Johnson & Johnson shares listed? Where are Johnson & Johnson shares listed?

Here are the trading details for Johnson & Johnson:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: JNJ
What kind of share is Johnson & Johnson?

Based on an overall assessment of its quality, value and momentum, Johnson & Johnson is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Johnson & Johnson share price forecast 2021?

Shares in Johnson & Johnson are currently priced at $158.46. At that level they are trading at 4.87% discount to the analyst consensus target price of 0.00.

Analysts covering Johnson & Johnson currently have a consensus Earnings Per Share (EPS) forecast of 9 for the next financial year.

How can I tell whether the Johnson & Johnson share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Johnson & Johnson. Over the past six months, the relative strength of its shares against the market has been -5.72%. At the current price of $158.46, shares in Johnson & Johnson are trading at 5.53% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Johnson & Johnson PE Ratio?

The Johnson & Johnson PE ratio based on its reported earnings over the past 12 months is 21.67. The shares are currently trading at $158.46.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Johnson & Johnson?

Johnson & Johnson's management team is headed by:

Alex Gorsky - CHM
Anne Mulcahy - LED
Ian Davis - IND
Peter Fasolo - CHO
Michael Ullmann - EVP
Paulus Stoffels - VMG
D. Scott Davis - IND
Mary Beckerle - IND
Joseph Wolk - CFO
Joaquin Duato - VMG
Michael Sneed - EVP
Jennifer Taubert - EVP
Ashley McEvoy - EVP
Jennifer Doudna - IND
Thibaut Mongon - EVP
Who are the major shareholders of Johnson & Johnson?

Here are the top five shareholders of Johnson & Johnson based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.67% (227.9m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 5.48% (144.0m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.71% (123.7m shares)
Vanguard Total Stock Market Index Fund Mutual Fund
Percentage owned: 2.82% (74.2m shares)
Vanguard 500 Index Fund Mutual Fund
Percentage owned: 2.01% (52.9m shares)
Similar to JNJ
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.